Viewing Study NCT00524459


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-03-03 @ 11:15 AM
Study NCT ID: NCT00524459
Status: TERMINATED
Last Update Posted: 2014-08-29
First Post: 2007-08-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Sponsor: Roswell Park Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: I 75506
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View